Načítá se...
Synthesis, Activity and Metabolic Stability of Non-Ribose Containing Inhibitors of Histone Methyltransferase DOT1L
Histone methyltransferase DOT1L is a drug target for MLL leukemia. We report an efficient synthesis of a cyclopentane-containing compound that potently and selectively inhibits DOT1L (K(i) = 1.1 nM) as well as H3K79 methylation (IC(50) ~ 200 nM). Importantly, this compound exhibits a high stability...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3686528/ https://ncbi.nlm.nih.gov/pubmed/23795283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/C3MD00021D |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|